دورية أكاديمية
أعرض في EDS

Wnt/β-catenin signaling pathway inhibitors, glycyrrhizic acid, solanine, polyphyllin I, crocin, hypericin, tubeimoside-1, diosmin, and rutin in medicinal plants have better binding affinities and anticancer properties: Molecular docking and ADMET study.

التفاصيل البيبلوغرافية
العنوان: Wnt/β-catenin signaling pathway inhibitors, glycyrrhizic acid, solanine, polyphyllin I, crocin, hypericin, tubeimoside-1, diosmin, and rutin in medicinal plants have better binding affinities and anticancer properties: Molecular docking and ADMET study.
المؤلفون: Egbuna C; Africa Centre of Excellence in Public Health and Toxicological Research (ACE-PUTOR) University of Port-Harcourt Port Harcourt Nigeria.; Department of Biochemistry, Faculty of Science University of Port Harcourt Port Harcourt Nigeria.; Department of Biochemistry, Faculty of Natural Sciences Chukwuemeka Odumegwu Ojukwu University Uli Nigeria., Patrick-Iwuanyanwu KC; Africa Centre of Excellence in Public Health and Toxicological Research (ACE-PUTOR) University of Port-Harcourt Port Harcourt Nigeria.; Department of Biochemistry, Faculty of Science University of Port Harcourt Port Harcourt Nigeria., Onyeike EN; Africa Centre of Excellence in Public Health and Toxicological Research (ACE-PUTOR) University of Port-Harcourt Port Harcourt Nigeria.; Department of Biochemistry, Faculty of Science University of Port Harcourt Port Harcourt Nigeria., Uche CZ; Department of Medical Biochemistry and Molecular Biology, Faculty of Basic Medical Sciences University of Nigeria Nsukka Nigeria., Ogoke UP; Biostatistics and Computation Unit, Department of Mathematics and Statistics University of Port Harcourt Port Harcourt Nigeria., Riaz M; Department of Allied Health Sciences University of Sargodha Sargodha Pakistan., Ibezim EN; Department of Biochemistry, Faculty of Natural Sciences Chukwuemeka Odumegwu Ojukwu University Uli Nigeria., Khan J; Department of Medical Laboratory Sciences, College of Applied Medical Sciences Majmaah University Al Majmaah Saudi Arabia.; Health and Basic Sciences Research Center Majmaah University Al Majmaah Saudi Arabia., Adedokun KA; Department of Immunology Roswell Park Comprehensive Cancer Center Buffalo New York USA., Imodoye SO; Department of Oncological Sciences, Huntsman Cancer Institute University of Utah Salt Lake City Utah USA., Bello IO; Department of Biological Sciences Southern Illinois University Edwardsville Edwardsville Illinois USA., Awuchi CG; School of Natural and Applied Sciences Kampala International University Kampala Uganda.
المصدر: Food science & nutrition [Food Sci Nutr] 2023 May 04; Vol. 11 (7), pp. 4155-4169. Date of Electronic Publication: 2023 May 04 (Print Publication: 2023).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101605473 Publication Model: eCollection Cited Medium: Print ISSN: 2048-7177 (Print) Linking ISSN: 20487177 NLM ISO Abbreviation: Food Sci Nutr Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Malden, MA : John Wiley & Sons, [2012]-
مستخلص: Wnt/β-catenin signaling pathway plays a role in cancer development, organogenesis, and embryogenesis. The abnormal activation promotes cancer stem cell renewal, proliferation, and differentiation. In the present study, molecular docking simulation and ADMET studies were carried out on selected bioactive compounds in search of β-catenin protein inhibitors for drug discovery against cancer. Blind docking simulation was performed using PyRx software on Autodock Vina. β-catenin protein (PDB ID: 1jdh) and 313 bioactive compounds (from PubChem database) with selected standard anticancer drugs were used for molecular docking. The ADMET properties of the best-performing compounds were calculated using SwissADME and pkCMS web servers. The results obtained from the molecular docking study showed that glycyrrhizic acid, solanine, polyphyllin I, crocin, hypericin, tubeimoside-1, diosmin, and rutin had the best binding interactions with β-catenin protein based on their binding affinities. Glycyrrhizic acid and solanine had the same and lowest binding energy of -8.5 kcal/mol. This was followed by polyphyllin I with -8.4 kcal/mol, and crocin, hypericin, and tubeimoside-1 which all had a binding energy of 8.1 kcal/mol. Other top-performing compounds include diosmin and rutin with binding energy of -8.0 kcal/mol. The ADMET study revealed that the following compounds glycyrrhizic acid, solanine, polyphyllin I, crocin, hypericin, tubeimoside-1, diosmin, rutin, and baicalin all violated Lipinski's rule of 5 which implies poor oral bioavailability. However, based on the binding energy score, it was suggested that these pharmacologically active compounds are potential molecules to be tested against cancer.
Competing Interests: The authors declare no conflict of interest whatsoever.
(© 2023 The Authors. Food Science & Nutrition published by Wiley Periodicals LLC.)
References: Plants (Basel). 2019 Nov 06;8(11):. (PMID: 31698813)
J Med Chem. 2015 May 14;58(9):4066-72. (PMID: 25860834)
Oncogene. 2017 Sep 28;36(39):5460-5472. (PMID: 28553956)
Oncotarget. 2017 Jan 31;8(5):8633-8647. (PMID: 28052009)
Sci Rep. 2017 Mar 03;7:42717. (PMID: 28256516)
J Biomol Struct Dyn. 2021 Aug;39(13):4618-4632. (PMID: 32567989)
J Cell Physiol. 2019 Jun;234(6):8040-8054. (PMID: 30341908)
Nat Commun. 2015 Mar 11;6:6536. (PMID: 25758784)
J Comb Chem. 1999 Jan;1(1):55-68. (PMID: 10746014)
J Oral Pathol Med. 2016 Aug;45(7):481-5. (PMID: 26861159)
Front Cell Dev Biol. 2021 Oct 26;9:753787. (PMID: 34765604)
J Hematol Oncol. 2020 Dec 4;13(1):165. (PMID: 33276800)
Methods Mol Biol. 2015;1263:243-50. (PMID: 25618350)
Front Oncol. 2019 Aug 02;9:708. (PMID: 31428581)
Front Immunol. 2019 Dec 16;10:2872. (PMID: 31921137)
Science. 2012 Jul 6;337(6090):59-64. (PMID: 22653731)
Bioengineered. 2022 Feb;13(2):2720-2731. (PMID: 34747319)
Skelet Muscle. 2013 Mar 05;3(1):5. (PMID: 23497616)
Trends Immunol. 2018 Oct;39(10):830-847. (PMID: 30213499)
Trends Cancer. 2018 Nov;4(11):741-754. (PMID: 30352677)
Curr Opin Chem Biol. 2015 Oct;28:39-46. (PMID: 26080277)
Trends Cell Biol. 2015 Apr;25(4):198-213. (PMID: 25540894)
Cells. 2019 Nov 07;8(11):. (PMID: 31703382)
Hepatology. 2019 Oct;70(4):1231-1245. (PMID: 30963603)
J Biomol Struct Dyn. 2022;40(22):12248-12259. (PMID: 34486940)
Hepatology. 2014 Aug;60(2):576-87. (PMID: 24492943)
Int J Mol Sci. 2020 Jul 06;21(13):. (PMID: 32640551)
Curr Opin Struct Biol. 2014 Dec;29:77-84. (PMID: 25460271)
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26. (PMID: 11259830)
Cancers (Basel). 2021 May 13;13(10):. (PMID: 34068065)
Leukemia. 2006 Jul;20(7):1211-6. (PMID: 16688229)
Cells. 2019 Aug 03;8(8):. (PMID: 31382613)
Cell. 2021 Jan 7;184(1):194-206.e14. (PMID: 33357447)
WIREs Mech Dis. 2021 May;13(3):e1511. (PMID: 33085215)
Annu Rev Cell Dev Biol. 2004;20:781-810. (PMID: 15473860)
Dev Cell. 2014 May 12;29(3):277-91. (PMID: 24768165)
Eur J Cancer. 2011 Feb;47(3):333-8. (PMID: 21112773)
Curr Med Chem. 2016;23(5):498-517. (PMID: 26758798)
Integr Cancer Ther. 2020 Jan-Dec;19:1534735420909895. (PMID: 32975458)
Sci Rep. 2016 May 17;6:26245. (PMID: 27185050)
Oncogene. 2017 Mar;36(11):1461-1473. (PMID: 27617575)
PLoS One. 2013 Oct 09;8(10):e77257. (PMID: 24130866)
Development. 2018 Jun 8;145(11):. (PMID: 29884654)
فهرسة مساهمة: Keywords: ADMET; Wnt signaling pathways; anticancer drugs; molecular docking; β‐catenin
تواريخ الأحداث: Date Created: 20230717 Latest Revision: 20230718
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC10345731
DOI: 10.1002/fsn3.3405
PMID: 37457177
قاعدة البيانات: MEDLINE
الوصف
تدمد:2048-7177
DOI:10.1002/fsn3.3405